Iovance Biotherapeutics, Inc. (IOVA) Income Annual - Discounting Cash Flows
IOVA
Iovance Biotherapeutics, Inc.
IOVA (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
Report Filing 2025-05-08 2025-02-27 2024-02-28 2023-02-28 2022-02-24 2021-02-25 2020-02-25 2019-02-28 2018-03-12 2017-03-09 2016-03-11 2015-03-16 2014-03-28 2013-09-23 2012-03-30 2011-04-14 2010-03-31 2009-02-17
Revenue 212.7 164.1 1.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 166.5 124 10.76 21.14 13.98 8.71 8.12 0.956 0.952 0.978 0.999 0.088 4.66 6.48 19.3 0 0.001 0
Gross Profit 46.2 40.08 -9.57 -21.14 -13.98 -8.71 -8.12 -0.956 -0.952 -0.978 -0.999 -9.34 -4.66 -6.48 -19.3 0 0 0
Operating Expenses 445 435.4 451 377.7 328.7 253.2 198.7 127.3 91.92 52.66 26.86 2.7 17.99 1.66 1.92 0.815 0.016 0.057
Research & Development 279.4 282.3 344.1 294.8 259 201.7 166 99.83 71.61 28.04 15.47 2.71 1.33 1.66 1.76 0 0 0
Selling, General and Administrative 160.2 153 106.9 104.1 83.66 60.21 40.85 28.43 21.26 17.2 12.39 9.34 4.66 6.48 19.3 0.757 0.014 0.026
Other Operating Expenses 5.38 0 0 -21.14 -13.98 -8.71 -8.12 -0.956 -0.952 7.43 -0.999 -9.34 12 -6.48 -19.14 0.058 0.001 0.032
Operating Income -398.8 -395.3 -460.6 -398.9 -342.7 -261.9 -206.9 -128.3 -92.88 -53.64 -27.86 -12.04 -22.64 -8.13 -21.22 -0.815 -0.016 -0.057
Net Non-Operating Interest 20.16 20.27 13.04 0 0.451 2.36 9.32 0 0.813 0.745 0 -0.006 -0.445 -2.42 -0.152 0 0 0
Interest Income 20.16 20.27 13.04 2.98 0.451 2.36 9.32 0 0.813 0.745 0.2 0 0 0 0 0 0 0
Interest Expense 0 0 0 2.98 0 0 0 0 0 0 0.2 0.006 0.445 2.42 0.152 0 0 0
Equity & Other Income/(Expense) 0 0 0 2.98 0 0 0 4.68 0 0 0.2 0.011 -2.3 7.25 -4.32 -0.793 0 0
Income Before Tax -378.6 -375 -447.5 -395.9 -342.3 -259.6 -197.6 -123.6 -92.06 -52.89 -27.66 -12.04 -25.38 -3.31 -25.69 -1.61 -0.016 -0.057
Income Tax Expense -3.26 -2.83 -3.48 -5.97 -14.43 -2.36 -10.48 4.68 -0.952 -0.978 -0.999 0 0.445 2.42 4.64 0.793 0 0
Income Attributable to Non-Controlling Interest 0 0 0 5.97 14.43 2.36 10.48 -4.68 0.952 0.978 0.999 0 -0.445 -2.42 -4.64 -0.793 0 0
Net Income -375.4 -372.2 -444 -395.9 -342.3 -259.6 -197.6 -123.6 -92.06 -52.89 -27.66 -12.04 -25.38 -3.31 -25.69 -1.61 -0.016 -0.057
Depreciation and Amortization 44.76 43.61 33.13 21.14 13.98 8.71 8.12 0.956 0.952 0.978 0.999 0.088 0.007 0.006 0.003 0.059 0.001 0.001
EBITDA -354 -351.7 -427.4 -377.7 -328.7 -253.2 -198.7 -127.3 -91.92 -52.66 -26.86 -11.95 -22.63 -8.13 -21.22 -0.756 -0.014 -0.056
Earnings Per Share (EPS) -1.24 -1.28 -1.89 -2.45 -2.14 -1.86 -1.5 -1.27 -1.41 -0.96 -0.62 -0.48 -2.6 -4.14 -33.84 -2.46 -0.041 -0.047
Diluted Earnings Per Share -1.24 -1.28 -1.89 -2.45 -2.14 -1.86 -1.5 -1.27 -1.41 -0.96 -0.62 -0.48 -2.6 -4.14 -33.84 -2.46 -0.041 -0.047
Weighted Average Shares Outstanding 322.9 289.9 235.1 159.3 153.4 138.3 124.3 97.28 65.24 55.27 44.41 24.99 9.76 0.799 0.759 0.652 0.381 1.21
Diluted Weighted Average Shares Outstanding 322.9 289.9 235.1 159.3 153.4 138.3 124.3 97.28 65.24 55.27 44.41 24.99 9.76 0.799 0.759 0.652 0.381 1.21
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us